Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Benitec Biopharma Ltd ADR

BNTC
Current price
10.30 USD -0.76 USD (-6.87%)
Last closed 11.06 USD
ISIN US08205P1003
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 215 389 040 USD
Yield for 12 month +261.39 %
1Y
3Y
5Y
10Y
15Y
BNTC
21.11.2021 - 28.11.2021

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California. Address: 3940 Trust Way, Hayward, CA, United States, 94545

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

24.00 USD

P/E ratio

Dividend Yield

Current Year

+216 000 USD

Last Year

+75 000 USD

Current Quarter

Last Quarter

Current Year

+108 000 USD

Last Year

-306 000 USD

Current Quarter

Last Quarter

-91 000 USD

Key Figures BNTC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -22 403 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -49.60 %
PEG Ratio
Return On Equity TTM -91.68 %
Wall Street Target Price 24.00 USD
Revenue TTM 7 000 USD
Book Value 4.68 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 12.50 %
Dividend Yield
Gross Profit TTM 75 000 USD
Earnings per share -5.51 USD
Diluted Eps TTM -5.51 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BNTC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History BNTC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:17
Payout Ratio
Last Split Date 26.07.2023
Dividend Date 18.11.2019

Stock Valuation BNTC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 10 457.68
Price Sales TTM 2 770.13
Enterprise Value EBITDA 0.27
Price Book MRQ 4.55

Financials BNTC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators BNTC

For 52 weeks

2.69 USD 13.29 USD
50 Day MA 9.77 USD
Shares Short Prior Month 33 107
200 Day MA 7.64 USD
Short Ratio 1.35
Shares Short 35 423
Short Percent 0.72 %